Back to search
Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II clinical trial evaluates tafasitamab and lenalidomide followed by tafasitamab and the carboplatin, etoposide and ifosfamide (ICE) regimen as salva…
In spite of high initial response rate after a first line treatment by R-polychemotherapy, cutaneous but also extra-cutaneous recurrences occur after 2 years in…